132 related articles for article (PubMed ID: 26364611)
1. RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma.
Wilky BA; Kim C; McCarty G; Montgomery EA; Kammers K; DeVine LR; Cole RN; Raman V; Loeb DM
Oncogene; 2016 May; 35(20):2574-83. PubMed ID: 26364611
[TBL] [Abstract][Full Text] [Related]
2. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
Bol GM; Vesuna F; Xie M; Zeng J; Aziz K; Gandhi N; Levine A; Irving A; Korz D; Tantravedi S; Heerma van Voss MR; Gabrielson K; Bordt EA; Polster BM; Cope L; van der Groep P; Kondaskar A; Rudek MA; Hosmane RS; van der Wall E; van Diest PJ; Tran PT; Raman V
EMBO Mol Med; 2015 May; 7(5):648-69. PubMed ID: 25820276
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation.
Aksenova M; Sybrandt J; Cui B; Sikirzhytski V; Ji H; Odhiambo D; Lucius MD; Turner JR; Broude E; Peña E; Lizarraga S; Zhu J; Safro I; Wyatt MD; Shtutman M
J Neuroimmune Pharmacol; 2020 Jun; 15(2):209-223. PubMed ID: 31802418
[TBL] [Abstract][Full Text] [Related]
4. RNA Helicase DDX3 Regulates RAD51 Localization and DNA Damage Repair in Ewing Sarcoma.
Randolph ME; Afifi M; Gorthi A; Weil R; Wilky BA; Weinreb J; Ciero P; Ter Hoeve N; van Diest PJ; Raman V; Bishop AJR; Loeb DM
bioRxiv; 2023 Jun; ():. PubMed ID: 37333164
[TBL] [Abstract][Full Text] [Related]
5. High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-X
Grissenberger S; Sturtzel C; Wenninger-Weinzierl A; Radic-Sarikas B; Scheuringer E; Bierbaumer L; Etienne V; Némati F; Pascoal S; Tötzl M; Tomazou EM; Metzelder M; Putz EM; Decaudin D; Delattre O; Surdez D; Kovar H; Halbritter F; Distel M
Cancer Lett; 2023 Feb; 554():216028. PubMed ID: 36462556
[TBL] [Abstract][Full Text] [Related]
6. RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma.
Randolph ME; Afifi M; Gorthi A; Weil R; Wilky BA; Weinreb J; Ciero P; Hoeve NT; van Diest PJ; Raman V; Bishop AJR; Loeb DM
iScience; 2024 Feb; 27(2):108925. PubMed ID: 38323009
[TBL] [Abstract][Full Text] [Related]
7. Targeting EYA3 in Ewing Sarcoma Retards Tumor Growth and Angiogenesis.
Wang Y; Pandey RN; Roychoudhury K; Milewski D; Kalin TV; Szabo S; Pressey JG; Hegde RS
Mol Cancer Ther; 2021 May; 20(5):803-815. PubMed ID: 33649104
[No Abstract] [Full Text] [Related]
8. Soft Tissue Ewing Sarcoma Cell Drug Resistance Revisited: A Systems Biology Approach.
Asfa S; Toy HI; Arshinchi Bonab R; Chrousos GP; Pavlopoulou A; Geronikolou SA
Int J Environ Res Public Health; 2023 Jul; 20(13):. PubMed ID: 37444135
[TBL] [Abstract][Full Text] [Related]
9. Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma.
Mooney B; Negri GL; Shyp T; Delaidelli A; Zhang HF; Spencer Miko SE; Weiner AK; Radaoui AB; Shraim R; Lizardo MM; Hughes CS; Li A; El-Naggar AM; Rouleau M; Li W; Dimitrov DS; Kurmasheva RT; Houghton PJ; Diskin SJ; Maris JM; Morin GB; Sorensen PH
Clin Cancer Res; 2024 Mar; 30(5):1022-1037. PubMed ID: 37812652
[TBL] [Abstract][Full Text] [Related]
10. Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress.
Croushore EE; Koppenhafer SL; Goss KL; Geary EL; Gordon DJ
Cancer Res Commun; 2023 Aug; 3(8):1580-1593. PubMed ID: 37599787
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 gRNA, a biological substrate, uncovers the potency of DDX3X biochemical activity.
de Bisschop G; Ameur M; Ulryck N; Benattia F; Ponchon L; Sargueil B; Chamond N
Biochimie; 2019 Sep; 164():83-94. PubMed ID: 30910425
[TBL] [Abstract][Full Text] [Related]
12. Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting Cells.
Visser LL; Bleijs M; Margaritis T; van de Wetering M; Holstege FCP; Clevers H
Cancer Res Commun; 2023 Oct; 3(10):2158-2169. PubMed ID: 37823774
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Hope on the Surface of Ewing Sarcoma.
Bailey KM
Clin Cancer Res; 2024 Mar; 30(5):934-936. PubMed ID: 38113033
[TBL] [Abstract][Full Text] [Related]
14. DDX3, a potential target for cancer treatment.
Bol GM; Xie M; Raman V
Mol Cancer; 2015 Nov; 14():188. PubMed ID: 26541825
[TBL] [Abstract][Full Text] [Related]
15. Akt and Hippo Pathways in Ewing's Sarcoma Tumors and Their Prognostic Significance.
Ahmed AA; Abedalthagafi M; Anwar AE; Bui MM
J Cancer; 2015; 6(10):1005-10. PubMed ID: 26366214
[TBL] [Abstract][Full Text] [Related]
16. DDX3 functions in antiviral innate immunity through translational control of PACT.
Lai MC; Sun HS; Wang SW; Tarn WY
FEBS J; 2016 Jan; 283(1):88-101. PubMed ID: 26454002
[TBL] [Abstract][Full Text] [Related]
17. RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3.
Xie M; Vesuna F; Tantravedi S; Bol GM; Heerma van Voss MR; Nugent K; Malek R; Gabrielson K; van Diest PJ; Tran PT; Raman V
Cancer Res; 2016 Nov; 76(21):6340-6350. PubMed ID: 27634756
[TBL] [Abstract][Full Text] [Related]
18. Analog sensitive chemical inhibition of the DEAD-box protein DDX3.
Floor SN; Barkovich KJ; Condon KJ; Shokat KM; Doudna JA
Protein Sci; 2016 Mar; 25(3):638-49. PubMed ID: 26650549
[TBL] [Abstract][Full Text] [Related]
19. Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9.
Fidaleo M; Svetoni F; Volpe E; Miñana B; Caporossi D; Paronetto MP
Oncotarget; 2015 Oct; 6(31):31740-57. PubMed ID: 26450900
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways.
Zhao L; Mao Y; Zhou J; Zhao Y; Cao Y; Chen X
Am J Cancer Res; 2016; 6(2):387-402. PubMed ID: 27186411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]